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Abstract
Objective: Mindfulness-based interventions (MBIs) can reduce risk of depressive relapse for people with a history of
recurrent depression who are currently well. However, the cognitive, affective and motivational features of depression and
anxiety might render MBIs ineffective for people experiencing current symptoms. This paper presents a meta-analysis of
randomised controlled trials (RCTs) of MBIs where participants met diagnostic criteria for a current episode of an anxiety or
depressive disorder.
Method: Post-intervention between-group Hedges g effect sizes were calculated using a random effects model. Moderator
analyses of primary diagnosis, intervention type and control condition were conducted and publication bias was assessed.
Results: Twelve studies met inclusion criteria (n = 578). There were significant post-intervention between-group benefits of
MBIs relative to control conditions on primary symptom severity (Hedges g=20.59, 95% CI =20.12 to 21.06). Effects were
demonstrated for depressive symptom severity (Hedges g=20.73, 95% CI =20.09 to 21.36), but not for anxiety symptom
severity (Hedges g=20.55, 95% CI = 0.09 to 21.18), for RCTs with an inactive control (Hedges g=21.03, 95% CI =20.40 to
21.66), but not where there was an active control (Hedges g= 0.03, 95% CI = 0.54 to 20.48) and effects were found for
MBCT (Hedges g=20.39, 95% CI =20.15 to 20.63) but not for MBSR (Hedges g=20.75, 95% CI = 0.31 to 21.81).
Conclusions: This is the first meta-analysis of RCTs of MBIs where all studies included only participants who were diagnosed
with a current episode of a depressive or anxiety disorder. Effects of MBIs on primary symptom severity were found for
people with a current depressive disorder and it is recommended that MBIs might be considered as an intervention for this
population.
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Introduction
Mindfulness refers to a state of consciousness that is char-
acterised by the self-regulation of attention towards present-
moment experiences coupled with an accepting, non-judgemental
stance towards these experiences [1]. Mindfulness-based interven-
tions (MBIs) are usually brief interventions (typically eight sessions)
delivered in a group setting and which incorporate mindfulness
meditation practice and principles. Mindfulness-Based Stress
Reduction (MBSR) [2] and Mindfulness-Based Cognitive Therapy
(MBCT) [3] are the most widely evaluated and available
approaches. MBSR was developed in the late 1970s and, with
its emphasis on stress reduction and improving wellbeing, has been
applied widely across physical health, mental health and non-
clinical populations. MBCT was developed in the 1990s and
integrates MBSR with elements from cognitive therapy for
depression. It was designed originally as a relapse prevention
intervention for people with a history of recurrent depression,
although in recent years MBCT has been extended to people with
current diagnoses of depressive and anxiety disorders.
There is evidence that MBCT approximately halves the risk of
relapse in comparison to standard care for people who are
currently well but who have experienced at least three prior
episodes of depression [4,5] and is comparable to anti-depressant
medication in reducing risk of relapse [6]. Because of promising
findings such as these, MBCT is now recommended in national
guidelines as a treatment choice for relapse prevention in recurrent
depression [7] and implementation of these recommendations is
underway [8]. Due to such promising findings there has been a
move to extend the reach of MBIs to people experiencing a
current episode or an anxiety or depressive disorder [9,10,11,12].
However, neither MBSR nor MBCT were developed for people
experiencing an acute episode of depression or anxiety [3,13,14].
Limited research has evaluated the effectiveness of these interven-
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tions within this currently distressed population and there are good
reasons to be cautious about extending the reach of MBIs in this
way.
In contrast to populations with a history of depression who are
not currently distressed, there are at least three reasons to suspect
that standard MBIs may not be of benefit to populations currently
meeting diagnostic criteria for an episode of a depressive or
anxiety disorder. First, MBIs invite participants to bring their full
awareness to current experiences. For people with a current
episode of an anxiety or depressive disorder their current
experiences are likely to include aversive automatic thoughts
[15,16] and unpleasant feelings of low mood or anxious arousal,
which may be difficult for the individual to attend to or accept. A
brief MBI of only eight sessions may be insufficient to enable
people to learn to attend to and accept such experiences. Whilst
MBCT emphasises decentring from unpleasant experiences,
rather than changing the content of experiences, cognitive
behaviour therapy (CBT) aims to change the content of negative
thoughts and beliefs and this may hold more intuitive appeal for
people who are currently depressed.
Second, cognitive processes common in anxiety and depressive
disorders may run counter to learning mindfulness [18]. Rumi-
nation [19,20], worry [21] and attentional biases [22] are
characteristic of depression and anxiety and mean that people
with a current episode of an anxiety or depressive disorder are
likely to become preoccupied by negative thoughts and feelings.
Attempting to distract from or avoid unpleasant experiences is also
common in depression and anxiety [23,24]. Mindfulness repre-
sents a different way of responding to experience by being aware of
experience (so not avoiding or distracting from it) without
attaching to it (so without perseverating) and this may be a
difficult skill to learn during a brief MBI that was not designed for
these populations.
Finally, there are motivational and concentration difficulties
that may present a challenge for people with a current episode of
an anxiety or depressive disorder to engaging in mindfulness
practice. Learning to self-regulate attention is seen as one of the
cornerstones of MBIs [1] however, regulating attention can be
difficult for people experiencing anxiety or depression [9,25,26].
Brief MBIs may not be sufficient to enable people experiencing a
current episode of an anxiety or depressive disorder to learn to
regulate their attention more effectively.
Whilst a number of meta-analyses have explored the effective-
ness of MBIs in relation to symptoms of anxiety and depression
[27,28,29,30,31,32], none directly address the effectiveness of
MBIs for people experiencing a current anxiety or depressive
episode in comparison to control conditions. Answering this
question will help to inform the appropriate implementation of
MBIs in routine clinical care.
The current meta-analysis tests the effectiveness of MBIs in
randomised controlled trials where all participants were diagnosed
with a current episode of an anxiety or depressive disorder. This is
operationalized as all participants in a study meeting diagnostic
criteria for a current episode of a DSM-IV (or later version) or
ICD-10 depressive or anxiety disorder [33,34]. MBIs in this study
were limited to interventions where mindfulness was core to the
intervention, that included mindfulness practice in each therapy
session and where daily mindfulness practice is recommended.
These criteria excluded relapse prevention trials where partici-
pants have a history of depression but who are not experiencing a
full current episode and trials where mindfulness practice is not
foregrounded.
This meta-analysis addressed the important question of whether
the conclusions about the effectiveness of MBIs can be extended to
people experiencing a current episode or an anxiety or depressive
disorder based on findings from RCTs. The primary outcome was
symptom severity for the target clinical problem. Secondary
outcomes of anxiety and depression symptom severity (irrespective
of diagnosis) were used. Moderator analyses looking at primary
diagnosis (anxiety or depressive disorder), control condition
(inactive or active) and intervention type (MBCT or MBSR) were
planned in the event of significant outcome heterogeneity.
Method
No published protocol has been published for this meta-analysis.
The PRISMA guidelines were adhered to [35]. See Checklist S1
for details (supporting information).
Search Strategy
Titles and abstracts from the following databases were searched:
MEDLINE, Web of Science, Scopus, ProQuest and PsycINFO for
published or unpublished studies from the first available year of
publishing until 4 July 2013. Reference sections of identified
papers were searched manually. The following search terms were
used: [(mindfulness or MBCT or MBSR) combined with (anxi* or
depress* or OCD or ‘‘obsessive compulsive’’ or ‘‘post-traumatic
stress disorder’’ or PTSD or agoraphobia or ‘‘panic disorder’’ or
‘‘acute stress disorder’’ or ‘‘acute stress reaction’’ or phobi*)
combined with (random* or RCT)].
In order to conduct a replicable search for unpublished data,
three leading clinical trial registers (www.clinicaltrialsregister.eu,
clinicaltrials.gov and www.controlled-trials.com/isrctn) were
searched to identify completed clinical trials of MBIs that had
not been published. The trial registers were searched with the term
‘mindfulness’ (multiple search terms were not possible) with no
restrictions placed on the search. All identified research team
members from relevant clinical trials were contacted by email for
details of their findings. In the event of failing to respond to email
requests a further two emails were sent.
Inclusion and Exclusion Criteria
Inclusion criteria were: (1) designs were Randomized Control
Trials; (2) participants aged 18 years or over; (3) mindfulness was a
core part of the MBI with mindfulness practice in each therapy
session and daily practice encouraged between sessions; (4) studies
included a psychometrically reliable and valid outcome measure of
depression or anxiety; and (5) data was presented for participants
who met full diagnostic criteria for a current episode of a DSM-IV
(or later version) or ICD-10 anxiety or depressive disorder.
Specifically, participants were required to meet full diagnostic
criteria for a DSM-IV depressive disorder (Major Depressive
Disorder not in full or partial remission) or anxiety disorder
(Generalised Anxiety Disorder, Panic Disorder, Agoraphobia,
Specific Phobia, Social Phobia, Obsessive Compulsive Disorder,
Post-Traumatic Stress Disorder or Acute Stress Disorder) or an
ICD-10 depressive episode or depressive disorder or anxiety
disorder (Phobic Anxiety Disorder, Agoraphobia, Social Phobia,
Specific Phobia, Panic Disorder, Generalised Anxiety Disorder,
Obsessive-Compulsive Disorder, Acute Stress Reaction or Post-
Traumatic Stress Disorder). Hypochondriasis (health anxiety) was
also an inclusion criterion given the central role that anxiety plays
in the disorder [33,34].
Exclusion criteria were: (1) participants had marked cognitive
impairment (e.g. learning disability or brain injury); (2) participants
were currently engaged in substance misuse; (4) MBI was not
delivered in a group format; (5) MBI was not delivered in-person
(e.g. self-help); and (6) studies not in the English language.
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Duplicate data was also excluded if the same outcomes were fully
or partially reported in another study. When this occurred, the
study with the larger sample size was retained.
Data Entry and Analysis
Means, standard deviations (sd) and number of participants for
the primary symptom measure and for measures of depression and
anxiety were entered into Review Manager version 5.2 (RevMan
5.2 [36]. Where available, intention-to-treat (ITT) data were
entered, where only completer data were available these were used
(see Table 1 for details). Post-intervention between-group effect
sizes were calculated using a random effects model (as this allows
generalisation of findings beyond the set of included studies) and
the following formula for Hedges g was used to calculate the effect
size for each study:
SMDi~
m1i{m2i
si
(1{
3
4Ni{9
)
where;
si~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(n1i{1)sd
2
1iz(n2i{1)sd
2
2i
Ni{2
s
SMDi= ‘standardised mean difference’; m1i = post-intervention
mean on chosen outcome measure for group 1; m2i = post-
intervention mean on chosen outcome measure for group 2;
Ni = total number of participants (across both conditions);
si = pooled standard deviation; n1i = number of participants in
group 1; n2i = number of participants in group 2; sd1i = standard
deviation of the post-intervention mean for group 1; sd2i = stan-
dard deviation of the post-intervention mean for group 2.
In essence, Hedges g effect size is the between-group difference
on the post-intervention mean scores for the chosen outcome
measure, divided by the pooled standard deviation (roughly
speaking, the average standard deviation of the two groups) and
then multiplied by a figure that adjusts the effect size to take
account of small sample sizes. This formula gives larger effect sizes
as the difference between the post-intervention means of the two
groups increase. By Cohen’s convention a small effect size is 0.2, a
medium effect size is 0.5 and a large effect size is 0.8.
Forest plots of post-intervention between-group effect sizes were
produced for each of the three outcome variables. To address
publication bias Rosenthal’s Fail-Safe N [37] was computed to
estimate the number of equal sample size unpublished studies of
zero effect that would be needed to reduce the mean effect size to
being non-significant in addition to producing funnel plots
showing study effect sizes against their standard error. A funnel
plot that shows points evenly distributed around the mean effect
size (shown as a vertical line) and forming a funnel shape indicates
that publication bias may not be present. Publication bias is
suggested if the funnel shape is distorted to show a disproportion-
ate number of studies with larger standard errors showing larger
than expected effect sizes. This is based on the assumption that
large-scale, funded RCTs tend to publish their findings (with large
scale studies produced smaller standard errors) whereas small-scale
studies may fail to publish non-significant or negative findings.
In order to assess the extent to which effect sizes were
significantly different from each other heterogeneity was assessed
using chi-square. A significant chi-square value indicates hetero-
geneity and that the studies cannot be considered to have recruited
from the same population. In this case, possible reasons for
heterogeneity can be explored. In order to do this moderator
analyses were planned to explore effects as a function of control
group (active or inactive), presenting problem (anxiety or
depressive disorder) and MBI-type (e.g. MBCT or MBSR).
The Jadad rating scale [38] was used to establish the quality of
each study using the following criteria: (a) the study was described
as randomized; (b) the method of randomization was appropriate;
(c) the study was described as double-blind, (d) the method of
double blinding was appropriate; and, (e) the study includes
information about all drop-outs and withdrawals. Each criterion
was awarded 1 point with a maximum score of 5.
Results
After duplicates were removed 657 published articles and 43
unpublished dissertations were identified, 30 records remained
after screening abstracts (see Figure 1 for full details). The full text
of these papers were reviewed and inclusion and exclusion criteria
applied which resulted in 12 studies included in the meta-analysis
[39,40,41,42,43,44,45,46,47,48,49,50]. See Figure 1 for a flow
diagram detailing the search and Table 1 for details of the 12
studies.
The search of clinical trial registers produced a total of 401
records. Titles and research protocols of trials which had closed to
recruitment were screened and the meta-analysis inclusion/
exclusion criteria were applied. Five trials were identified as
possible candidates following this screen. All named members of
the research teams on these trials were contacted by email for
information about the studies, however no data meeting our
search criteria were made available.
Participant Characteristics
There were a total of 578 participants across the 12 studies. All
participants had a DSM-IV confirmed diagnosis of a major
depressive disorder or an anxiety disorder. The DSM-IV diagnosis
of participants was major depressive disorder (4 studies, total
n = 160) or an anxiety disorder (8 studies, total n = 418: social
anxiety disorder (3 studies, total n = 120), generalised anxiety
disorder (1 study, total n = 31), PTSD (1 study, total n = 47), or
health anxiety (1 study, total n = 74). Two studies included
participants with a range of DSM-IV anxiety disorders (n = 146).
Table 1 shows that the mean age of participants were typically
in the 30s or 40s with mean ages ranging from 21 years to 52
years. Whilst most studies did not report age ranges, the standard
deviation of ages suggest that most, if not all, participants were of
working age (18–65 years). All but one study reported use of
psychotropic medication. This ranged from 14% in one study to
100% in another study.
Mindfulness-Based Interventions
Mindfulness-based interventions were Mindfulness-Based Cog-
nitive Therapy (MBCT=6), Mindfulness-Based Stress Reduction
(MBSR=5) and Person-Based Cognitive Therapy (PBCT=1).
MBCT and MBSR are group approaches consisting of eight 2 to 3
hour weekly sessions plus one whole day session. They involve a
range of mindfulness practices which range between 3 and 40
minutes in length, with more than one practice per session. Daily
mindfulness practice between sessions is encouraged and supported
through audio recordings. In addition there is in-session discussion
of what was learned during mindfulness practice. PBCT for
depression involves twelve 90-minute sessions. There are two
mindfulness practices in each session (a 5 minute practice and a 10
minute practice) along with Socratic discussion of what was learned
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and daily mindfulness practice is encouraged and supported
through mindfulness practice audio recordings. Both MBCT and
PBCT include elements of cognitive therapy with a greater
emphasis placed on cognitive therapy in PBCT than in MBCT.
Control Conditions
There were five active control conditions (group CBT=4,
group psychoeducation = 1) and seven inactive control conditions
(TAU=5, wait-list = 1, aerobic exercise = 1).
Attrition
There was wide variability in the number of participants
dropping out from MBI with attrition ranging from 8 percent to
38 percent (median attrition= 15.5%).
Meta-Analysis Findings
Effect of MBI on primary symptom severity. A random
effects model (see Figure 2) showed there was a post-intervention
between-group difference in favour of MBI on primary symptom
severity with a medium effect size (Hedges g=20.59, 95% CI=2
1.06 to 20.12) that was statistically significant (z(11) = 2.48,
p=0.01). Heterogeneity was significant (x2(11) = 76.32, p,.001)
and so moderator analyses were performed on primary diagnosis
(depressive or anxiety disorder), type of control condition (active or
inactive) and type of intervention.
Primary symptom effect size as function of primary
diagnosis. Moderator analysis showed no significant differences
in primary symptom severity between those studies targeting
depressive disorders and those studies targeting anxiety disorders
Figure 1. PRISMA (2009) Flow Diagram.
doi:10.1371/journal.pone.0096110.g001
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(x2(1) = 0.15, p=0.69). However, analyses within subgroups (see
Figure 2) showed that whilst there were significant post-interven-
tion between-group differences for people diagnosed with a
depressive disorder with a large effect size in favour of MBI on
primary symptom severity (Hedges g=20.73, 95% CI=21.36 to
20.09, z(3) = 2.24, p= .03) effects for anxiety disorders were non-
significant (Hedges g=20.55, 95% CI=21.18 to 0.09,
z(7) = 1.69, p= .09).
Primary symptom effect size as function of control
condition type. Figure 3 shows that moderator analysis found
a significant difference between studies with active and inactive
control conditions (x2(1) = 6.60, p= .001). Whilst MBI outper-
Figure 3. Forest Plot of the effect of MBIs in comparison to control conditions on primary symptom severity by control condition
type (active versus inactive) for people with depressive disorder and anxiety disorder diagnoses.
doi:10.1371/journal.pone.0096110.g003
Figure 2. Forest Plot of MBIs in comparison to control conditions on severity of primary symptom for people with depressive
disorder and anxiety disorder diagnoses.
doi:10.1371/journal.pone.0096110.g002
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formed inactive control conditions with a large effect size when
looking at primary symptom severity (Hedges g=21.03, 95%
CI=21.66 to 20.40, z(6) = 3.20, p= .001) MBI was not
significantly different than active control conditions (Hedges
g=0.03, 95% CI=20.48 to 0.54, z(4) = 0.13, p= .90). This
suggests that the effect of MBIs on primary symptom severity
varied as a function of control condition with MBIs being more
effective than inactive control conditions but not more effective
than active control conditions.
Primary symptom effect size as function of intervention
type (MBCT or MBSR). Moderator analysis was also conduct-
ed on the effect of intervention type on primary symptom severity
for studies MBCT and MBSR (see Figure 4). The single PBCT
study was not included in this analysis. This analysis showed no
significant differences between MBI subgroups (x2(1) = 0.42,
p= .52). However, when looking at these subgroups separately
there was no significant effect of MBSR on primary symptom
severity (Hedges g=0.75, 95% CI=21.81 to 0.31, z(4) = 1.39,
p = .16) but there was a significant effect of MBCT with a small to
medium effect size (Hedges g=0.39, 95% CI=20.63 to 20.15,
z(5) = 3.23, p,.01).
Effect of MBI on depressive and anxiety symptom
severity (irrespective of diagnosis). Given the high co-
morbidity between anxiety and depression [51], meta-analyses
were also conducted on depressive and anxiety symptom severity,
irrespective of primary diagnosis (see Figure 5 and Figure 6
respectively). All the studies included a measure of depressive
symptom severity. There was a post-intervention between-group
effect in favour of MBI on depressive symptom severity with a
medium effect size (Hedges g=20.64, 95% CI=21.00 to 20.28)
Figure 5. Forest Plot of the effect of MBIs in comparison to control conditions on depressive symptom severity for people with
depressive disorder and anxiety disorder diagnoses.
doi:10.1371/journal.pone.0096110.g005
Figure 4. Forest Plot of the effect of MBIs in comparison to control conditions on primary symptom severity by intervention type
(MBCT versus MBSR) for people with depressive disorder and anxiety disorder diagnoses.
doi:10.1371/journal.pone.0096110.g004
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that was statistically significant (z(11) = 3.45, p,.001) but effect
sizes were heterogeneous (x2(11) = 46.69, p,.001). Nine studies
included a measure of anxiety symptom severity and there was a
non-significant post-MBI between-group difference in anxiety
symptom severity (Hedges g=20.52, 95% CI=21.11 to 0.06,
z(8) = 1.77, p= .08) and heterogeneous effect sizes (x2(8) = 63.55,
p,.001). These results suggest that MBIs had an effect of
depressive symptom severity relative to control conditions but
did not have a significant effect on anxiety symptom severity.
Publication bias. In terms of publication bias, the funnel
plot for primary symptom severity (see Figure 7) suggests a slight
bias towards publishing small sample size studies with findings in
favour of MBI. This is shown by the disproportionate number of
small studies (shown towards the bottom of the figure) with larger
effect sizes than would be suggested by the overall effect. However,
Rosenthal’s Fail-Safe N analyses found that an additional 264
studies showing no intervention effect would be needed to reduce
the overall effect size on primary symptom severity to being non-
significant. This indicates that whilst a publication bias may be
present, a substantial number of unpublished studies would need
to exist to render these effects non-significant.
Study quality and effect sizes. Jadad scores for studies
ranged from 2 to 5 (mean= 2.83, sd = 0.83). The correlation
between Jadad ratings and study effect sizes was non-significant for
primary symptom severity (r(12) =2.20, p= .54), depressive
symptom severity (r(12) =2.14, p= .66) and for anxiety symptom
severity (r(8) = .26, p= .53). This shows no significant relationship
between study quality and study effect size.
Discussion
This meta-analysis tested the effectiveness of MBIs for people
diagnosed with a current episode of a depressive or anxiety
disorder in comparison to control conditions. This analysis was
restricted to randomised controlled trials where all participants
were confirmed as meeting diagnostic criteria for a current episode
of a depressive or anxiety disorder and where intervention
participants were assigned to MBIs that foregrounded mindfulness
principles and practice as a core feature of the intervention. We
Figure 7. Funnel plot of effect sizes by standard error for primary symptom severity.
doi:10.1371/journal.pone.0096110.g007
Figure 6. Forest Plot of the effect of MBIs in comparison to control conditions on anxiety symptom severity for people with
depressive disorder and anxiety disorder diagnoses.
doi:10.1371/journal.pone.0096110.g006
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found that MBIs, in comparison to control conditions, resulted in
significantly lower levels of symptom severity for the primary
problem with a medium between-group effect size. This suggests
that, despite the cautions outlined in the Introduction, these
interventions are associated with significant primary symptom
benefits for these populations.
Findings in Context
Published meta-analyses of MBIs for mental health conditions
are limited for three reasons. Firstly, some are limited in their
methodological rigor by foregrounding pre-post effect sizes and
not providing a robust comparison to control conditions [28,30] or
by reporting between-group effect sizes but including non-
randomised trials [29,32]. Second, some are limited by having
overly broad inclusion criteria for the type of intervention, such as
including interventions that do not foreground mindfulness
practice [29,32], calling into question their relevance when
addressing the effectiveness of MBIs. Finally, some are limited
by participant characteristics with some existing meta-analysis not
restricting eligibility to only those studies with participants meeting
diagnostic criteria for a current anxiety or depressive disorder
[27,29,31] whereas some focus on specific disorders [29,32] rather
than considering anxiety and depressive disorders together which
is arguably a false dichotomy given the high co-morbidity between
depressive and anxiety disorders [51]. This is the first published
meta-analysis of RCTs that demonstrates that people experiencing
a current episode of an anxiety or depressive disorder can benefit
from MBIs. However, effect sizes were heterogeneous and
moderator analyses revealed a more nuanced picture.
Effects on Depression
There were significant benefits on primary symptom severity of
MBIs relative to control conditions for people with a primary
depressive disorder diagnosis. There were also significant benefits
of MBI on depressive symptom severity across the studies,
irrespective of primary presenting problem. Effects of MBI on
depressive symptom severity replicates and extends findings from
previous meta-analyses [28,29]. Findings for effects on depression
are in line with effect sizes reported in a recent meta-analysis [29]
where a post-intervention between-group effect size of 20.53 was
found on depressive symptom severity, which is somewhat smaller
than the effect size of 20.73 found in the current meta-analysis.
This previous meta-analysis however was not restricted to studies
where participants were confirmed as meeting diagnostic criteria
for major depressive disorder. Therefore, the finding from the
current meta-analysis makes an important and novel contribution
to the clinical literature as it shows that people experiencing a
current episode of major depressive disorder can gain symptom
benefit from MBIs.
We suggested earlier that certain features of depression could
present a barrier to people engaging in and benefitting from MBIs.
The aversive content of depressive thoughts and feelings [15]
could present a challenge to engaging in mindfulness practice, the
process of rumination, common in depression [20], runs counter
to mindfulness and the attentional and motivational features of
depression [22] could make it difficult to self-regulate attention [1]
and commit to regular mindful practice. Despite these potential
barriers we found that people experiencing a current episode of a
depressive disorder could benefit from MBIs.
Effects on Anxiety
Although moderator analyses did not show that the effects of
MBIs on primary symptom severity varied as a function of primary
problem, the effects on anxiety symptom severity were not
statistically significant either when just looking at those people
with a confirmed anxiety disorder diagnosis or when looking at
anxiety outcomes across the full-range of studies. Although the
mean effect size for the effect of MBIs on anxiety symptom severity
was in the moderate range (Hedges g=20.52), the 95%
confidence interval for this effect crossed zero (21.11 to 0.06).
Moreover, one of the studies included in this analysis had a low
Jadad rating [40] and produced an unusually large effect size of 2
5.29. If this study is removed the mean effect size becomes small
(Hedges g=20.17; 95% confidence interval: 20.54 to 0.21).
Overall, we suggest that caution should be applied in offering
MBIs for populations with anxiety disorders or where anxiety
symptom severity is a target. However, the failure to find an effect
on anxiety symptom severity could be due to a lack of power in
this analysis and further studies are needed before we can draw
definitive conclusions about the beneficial effects of MBIs for
people with a current anxiety disorder.
These findings appear to be in contrast to a recent meta-analysis
of mindfulness and acceptance-based interventions [32] where
significant between-group effects were reported for controlled
trials on anxiety symptom severity for people with a confirmed
anxiety disorder. However, the between-group analysis in that
paper included only five studies, including two studies, with the
largest effect sizes, that were not MBIs. The current meta-analysis
used a strict definition of MBIs in order to isolate, as well as
possible, the effect of mindfulness principles and practice on
symptom change and findings suggest that MBIs may not be
effective at targeting anxiety symptom severity.
Effects as a Function of Intervention Type
Although there were no significant differences between MBCT
and MBSR on primary symptom outcomes, subgroup analyses
found that effects on primary symptom severity were significant for
MBCT but not for MBSR. This replicates the finding by a
previous meta-analysis [32] where a non-significant advantage for
MBCT over MBSR was found. These findings, when taken in
conjunction with the effects on depression outlined above, support
the use of MBCT for people with a current diagnosis of a
depressive disorder and extends the evidence for MBCT in
depression, which was originally shown to be effective at reducing
the risk of relapse for people who are in full or partial remission
but who have experienced three or more episodes of depression
[4,5].
The single PBCT trial was not included in the moderator
analysis however, it produced the largest effect size on depressive
symptom severity (Hedges g=21.81) for the studies of depressive
disorders. Indeed, the effect size was more than twice as large as
any other effect size in this particular analysis. The other trials in
this analysis were of MBCT and it is of note that PBCT was
originally developed for people currently experiencing severe
mental health difficulties [52] and it may therefore be the case that
PBCT lends itself well to people experiencing a current episode of
depression. Mindfulness practices in PBCT are shorter (5 to 10
minutes) than in MBCT (up to 30 to 40 minutes) and frequent
verbal guidance is given because of a concern that lengthier
practices or extended periods of silence may be particularly
challenging for people experiencing current distress [52]. Despite
shorter mindfulness practices, findings from the current analysis
show that the effect of PBCT on primary depressive symptom
severity is not less than the effect of MBCT, although further
studies of PBCT are required before drawing firm conclusions.
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Effects as a Function of Control Condition Type
Moderator analyses of control condition type showed that whilst
effects of MBIs on symptom severity remained for studies using
inactive control conditions (such as waiting lists), these effects
disappeared when comparing MBIs to active control conditions.
Four of the five studies which used an active control condition
compared MBIs to group cognitive behaviour therapy (CBT).
Two of these studies were for social anxiety disorder [44,47], one
was of MBCT for major depressive disorder [45] and one of
MBSR for mixed anxiety disorders [39]. The mean effect size
between MBIs and active control conditions on primary symptom
severity was negligible (Hedges g=0.03) which suggests that MBIs
may be no less effective than group CBT. Whilst future non-
inferiority studies are needed to compare MBIs with group CBT,
particularly for the full range anxiety disorders, the evidence from
the current meta-analysis shows promise for MBI as an alternative
to group CBT.
Attrition
A median of 15.5 percent of participants dropped out from the
MBI conditions identified in this review. This is similar to the
mean drop-out rate of 16.1 percent from a meta-analysis of RCTs
of CBT [53]. This suggests that dropout rates from MBIs for
people diagnosed with a current anxiety or depressive episode is
not higher than would be expected from the broader psychother-
apy literature. This is important as it suggests that engagement
with MBIs is possible for people when they are experiencing a
current episode of a depressive or anxiety disorder. Dropout rates
were variable across the studies however, ranging from 8 percent
to 37 percent and reasons for variability in dropout should be
explored in future studies.
Limitations
Research exploring the effectiveness of MBIs in populations
with current diagnoses of anxiety or depression are in their
infancy, and the evidence base is somewhat limited in both
quantity and quality. Only 12 studies met our inclusion criteria,
and of these the majority of studies (N= 7) compared MBI to
inactive control conditions. These studies permit only a weak
interpretation of the treatment effects, and do not allow the
benefits of mindfulness practice and principles to be separated out
from non-specific group therapeutic factors such as universality,
altruism and group cohesion [54]. MBIs are purported to work
through improving mindfulness which in turn is thought to reduce
symptom severity and improve wellbeing. This is supported by
evidence that improvements in mindfulness mediate symptom
improvements following MBCT for recurrent depression [55]. In
addition, a recent meta-analysis demonstrated enhanced mindful-
ness skills following MBIs in comparison to control conditions for
people from non-clinical populations [17]. The preponderance of
RCTs comparing to inactive control conditions limits the
opportunities to explore mechanisms of change given the potential
role of non-specific therapeutic factors in enhancing mindfulness
and producing positive outcomes. Future research of MBIs should
therefore aim to control for non-specific and non-mindfulness
factors in order to isolate the potential benefits of learning
mindfulness from other elements of MBIs.
The methodological quality of several of the included studies
was poor, as shown by low Jadad ratings in some cases. Despite
this, there were non-significant associations between Jadad ratings
and effect sizes which indicates that there was not a bias towards
lower quality trials reported larger effect sizes. Whilst seven of the
12 studies reported intention-to-treat data, five studies only
reported completer data which potentially introduces some bias
in favour of MBI, as it is possible that non-completers would have
benefitted less than therapy completers. However this does not
appear to be the case here as the mean effect size on primary
symptom severity for the studies reporting completer data was
similar to the effect size for studies reporting intention-to-treat data
(Hedges g=20.84 and 20.73 respectively).
Too few of the studies included long term follow-up of
participants to allow for a separate analysis. For people
experiencing a current episode of a depressive or anxiety disorder
not only do we want our therapies to be of immediate benefit, we
hope that they will continue to provide benefit in the longer term.
Without following participants up it is not possible to know
whether MBI provides long lasting benefit in relation to symptom
reduction and future research in this area should include a follow-
up period.
Whilst this meta-analysis set out to answer the question of
efficacy of MBI for depressive and anxiety disorders, the range of
anxiety disorders was not well represented. Whilst RCTs of social
anxiety disorder [42,44,47], generalised anxiety disorder [40],
health anxiety [46] and post-traumatic stress disorder [43] were
included, no RCTs of MBIs specifically targeting obsessive
compulsive disorder (see [56] for a recent review), agoraphobia,
panic disorder or simple phobia could be found. This limits
conclusions that can be drawn here about the effectiveness of
MBIs transdiagnostically across anxiety conditions.
Efforts were made to limit the impact of publication bias on
findings. Unpublished dissertations and theses were included in the
search strategy and three of the major clinical trials registers were
searched in order to find potential unpublished studies. No
unpublished data were made available. Graphical (funnel plots)
and statistical (Fail-Safe N) methods were used in order to assess
for possible publication bias and its potential impact on findings.
Whilst the funnel plot indicated a potential for publication bias
(meaning that there may be unpublished trials with non-significant
or negative findings), the Fail-Safe N analysis suggested that a large
number of studies with nil effect would be needed to render the
primary analysis non-significant. This allows us to have some
confidence in our findings despite the omission of data from
unpublished studies.
Clinical Implications
This meta-analysis suggests that people meeting diagnostic
criteria for a current episode of a depressive disorder can benefit
from MBIs. However, the studies of MBIs for depression were
limited to MBCT or PBCT; none of the studies were of MBSR.
Therefore our findings only apply to MBCT and PBCT and not to
MBSR and we cannot comment on the basis of our analysis on the
effects of MBSR on current depression. Our findings suggest that
people experiencing a current depressive episode can benefit from
MBCT or PBCT despite the negative thoughts and feelings
associated with depression, thinking processes that orient attention
towards or away from negative content and motivational and
attentional problems.
The studies targeting depression recruited from primary care
and secondary care populations which suggests that MBIs might
usefully be offered in both settings to people experiencing a
depressive episode. It is of note however that the mindfulness-
based intervention used in the PBCT trial [48] was especially
adapted for secondary care populations [52]. None of the studies
specifically recruited people from inpatient settings and therefore it
would be premature to extend findings to this setting.
Finally, given the paucity of evidence in their favour, we would
caution against offering MBIs as a first line intervention for people
experiencing a primary anxiety disorder. Not only did we find few
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studies targeting specific anxiety disorders, but those we did find
suggest that MBIs may not be effective at targeting primary
symptom severity for people experiencing an anxiety disorder.
There are other, well-evidenced interventions for the range of
anxiety disorders [57,58] and findings from the current meta-
analysis would suggest great caution if offering MBIs to this
population as a first line intervention instead of a well-established
therapy.
Conclusions
This is the first published meta-analysis of RCTs that evaluates
the effectiveness of MBIs for people experiencing a current episode
of a depressive or anxiety disorder. We found significant benefits
relative to control conditions for primary symptom severity for
people experiencing a current episode of depression following
MBIs (namely MBCT or PBCT). Moreover, the analysis indicated
that MBIs may produce similar outcomes to group CBT and
therefore we suggest that MBCT or PBCT may be offered
alongside other evidence-based interventions for people experi-
encing a current depressive episode in order to increase patient
choice. We failed however to find support for MBIs for people
experiencing a current episode of an anxiety disorder. This may
well be due to the preponderance of small, underpowered studies
but until further, adequately powered trials are conducted caution
should be applied before offering MBIs as a first line intervention
for anxiety disorders.
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